🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ray Y. Chen

National Institutes of Health

ORCID: 0000-0001-6344-1442

Also affiliated with National Institute of Allergy and Infectious Diseases, Office of Extramural Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial”.

A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial

Nature Medicine(2024)10.1038/s41591-024-02829-7

N/A

1.3DataRank · unranked

50 citations

Clifton E. Barry, Alex Carlton, Ray Y. Chen, Matt Davies, Veronique de Jager +14 more

Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis

The Lancet Microbe(2021)10.1016/s2666-5247(21)00058-6

N/A

0.561DataRank · unranked

41 citations

Xiang Yu, Bronwyn Smith, Xin Liu, Jingcai Gao, Andreas H. Diacon +18 more

A prospective observational cohort study of HIV infection in Indonesia: baseline characteristics and one-year mortality

BMC Infectious Diseases(2025)10.1186/s12879-024-10354-8

N/A

0.241DataRank · unranked

4 citations

Evy Yunihastuti, Rudi Wisaksana, Nia Kurniati, Dona Arlinda, Muhammad Karyana +91 more

PET/CT guided tuberculosis treatment shortening: a randomized trial

medRxiv(2024)10.1101/2024.10.03.24314723

N/A

0DataRank · unranked

10 citations

Ray Y. Chen, Xiang Yu, Bronwyn Smith, Xin Liu, Jingcai Gao +50 more

Predicting TB treatment outcomes using baseline risk and treatment response markers: developing the PredictTB early treatment completion criteria

Gates Open Research(2020)10.12688/gatesopenres.13179.1

N/A

0DataRank · unranked

0 citations

Jing Wang, Lili Liang, Yingda L. Xie, Stephanus T. Malherbe, Jill Winter +9 more

Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis

ERJ Open Research(2025)10.1183/23120541.01016-2025

N/A

0DataRank · unranked

0 citations

Elisa Nemes, Michèle Tameris, Simon C. Mendelsohn, Michelle Fisher, Elizabeth Filander +15 more

Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis

Science Translational Medicine(2021)10.1126/scitranslmed.abd7618

N/A

0DataRank · unranked

47 citations

Veronique de Jager, Ray Y. Chen, Lori E. Dodd, Praveen Paripati, Laura E. Via +19 more

Surveillance and agnostic capture sequencing of samples from individuals with rash-associated illness in Mali indicates regional transmission of measles virus from West and Central Africa

Infection Genetics and Evolution(2024)10.1016/j.meegid.2024.105691

N/A

0DataRank · unranked

1 citations

John P. Collins, A. Koné, Noumou Y. Keita, Issa Cisse, Klèma M. Koné +23 more